About Pulmongene
Pioneering Fibrosis Innovation and Beyond
Our Mission
At Pulmongene, we are dedicated to transforming the treatment landscape for respiratory disorders and fibrotic diseases through pioneering scientific discoveries.
With our breakthrough medicines, we aim to stop the progression of these chronic diseases, improve patient outcomes, and ultimately, advance toward lasting cures.
Our Vision
We aim to lead the biotech industry in IPF research and drug development, setting new standards for efficacy and safety. Our vision is to create a future where IPF is no longer life-threatening but a manageable condition, offering hope and restoring quality of life. Through collaboration with patients, healthcare providers, and research communities, we are dedicated to bringing novel therapies with speed, compassion, and integrity.
Our focus is on identifying novel molecular drivers of lung and fibrotic diseases, and developing first-in-class therapies for patients worldwide.